Publications by authors named "Bob Brown"

Claim this Profile
R
RNAi mediated silencing of STAT3/PD-L1 in tumor-associated immune cells induces robust anti-tumor effects in immunotherapy resistant tumors.
Shanthi Ganesh, Min Ju Kim, Jenny Lee, Xudong Feng, Krisjanis Ule, Bob D Brown

Mol Ther· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-in-human randomized study of RNAi therapeutic RG6346 for chronic hepatitis B virus infection.
Edward J Gane, Won Kim, Tien Huey Lim, Pisit Tangkijvanich, Jung-Hwan Yoon, Bob D Brown

J Hepatol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Therapeutic RNA interference: A novel approach to the treatment of primary hyperoxaluria.
Thomas A Forbes, Bob D Brown, Chengjung Lai

Br J Clin Pharmacol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual G9A/EZH2 Inhibition Stimulates Antitumor Immune Response in Ovarian High-Grade Serous Carcinoma.
Pavlina Spiliopoulou, Sarah Spear, Hasan Mirza, Ian Garner, Lynn McGarry, Bob Brown

Mol Cancer Ther· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatic Lactate Dehydrogenase A: An RNA Interference Target for the Treatment of All Known Types of Primary Hyperoxaluria.
Gema Ariceta, Kelly Barrios, Bob D Brown, Bernd Hoppe, Ralf Rosskamp

Kidney Int Rep· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reducing pressure ulcers across multiple care settings using a collaborative approach.
Julia Wood, Bob Brown, Annette Bartley, Andreia Margarida Batista Custódio Cavaco, Anthony Paul Roberts

BMJ Open Qual· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Direct Inhibition of β-catenin: A new strategy for colorectal cancer.
Shanthi Ganesh, Bob D Brown, Marc Abrams

Oncoscience· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RNAi-Mediated β-Catenin Inhibition Promotes T Cell Infiltration and Antitumor Activity in Combination with Immune Checkpoint Blockade.
Shanthi Ganesh, Xue Shui, Kevin P Craig, Jihye Park, Weimin Wang, Bob D Brown

Mol Ther· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Specific Inhibition of Hepatic Lactate Dehydrogenase Reduces Oxalate Production in Mouse Models of Primary Hyperoxaluria.
Chengjung Lai, Natalie Pursell, Jessica Gierut, Utsav Saxena, Wei Zhou, Bob D Brown

Mol Ther· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of Glycogen Synthase II with RNAi Prevents Liver Injury in Mouse Models of Glycogen Storage Diseases.
Natalie Pursell, Jessica Gierut, Wei Zhou, Michael Dills, Rohan Diwanji, Bob D Brown

Mol Ther· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Î
β-Catenin mRNA Silencing and MEK Inhibition Display Synergistic Efficacy in Preclinical Tumor Models.
Shanthi Ganesh, Xue Shui, Kevin P Craig, Martin L Koser, Girish R Chopda, Bob D Brown

Mol Cancer Ther· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Direct Pharmacological Inhibition of β-Catenin by RNA Interference in Tumors of Diverse Origin.
Shanthi Ganesh, Martin L Koser, Wendy A Cyr, Girish R Chopda, Junyan Tao, Bob D Brown

Mol Cancer Ther· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacists' reactions to natural disasters: From Japan to Canada.
Denise A Epp, Yoshirou Tanno, Anita Brown, Bob Brown

Can Pharm J (Ott)· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of Glycolate Oxidase With Dicer-substrate siRNA Reduces Calcium Oxalate Deposition in a Mouse Model of Primary Hyperoxaluria Type 1.
Chaitali Dutta, Nicole Avitahl-Curtis, Natalie Pursell, Marita Larsson Cohen, Benjamin Holmes, Bob D Brown

Mol Ther· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Germline polymorphisms in an enhancer of PSIP1 are associated with progression-free survival in epithelial ovarian cancer.
Juliet D French, Sharon E Johnatty, Yi Lu, Jonathan Beesley, Bo Gao, Bob Brown

Oncotarget· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spanish-speaking patients' satisfaction with clinical pharmacists' communication skills and demonstration of cultural sensitivity.
Dawn N Kim-Romo, Jamie C Barner, Carolyn M Brown, José O Rivera, Aida A Garza, Bob Brown

J Am Pharm Assoc (2003)· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ABCA transporter gene expression and poor outcome in epithelial ovarian cancer.
Ellen L Hedditch, Bo Gao, Amanda J Russell, Yi Lu, Catherine Emmanuel, Bob Brown

J Natl Cancer Inst· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Underwriting mortality risk using cognitive function tests.
Guizhou Hu, Ashlee Duncan, Bob Brown

J Insur Med· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Knockdown of β-catenin with dicer-substrate siRNAs reduces liver tumor burden in vivo.
Henryk Dudek, Darren H Wong, Rokhand Arvan, Anee Shah, Kathleen Wortham, Bob D Brown

Mol Ther· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantitative analysis of dicer substrate oligonucleotides in mouse liver by ultra-high-performance liquid chromatography-electrospray ionization tandem mass spectrometry.
Kaisheng Jiao, Aftab Rashid, Sujit K Basu, Shuhao Zhu, Bob D Brown

Assay Drug Dev Technol· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glutathione and Bcl-2 targeting facilitates elimination by chemoradiotherapy of human A375 melanoma xenografts overexpressing bcl-xl, bcl-2, and mcl-1.
Salvador Mena, María L Rodriguez, Angel Ortega, Sonia Priego, Elena Obrador, Bob D Brown

J Transl Med· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of BCL-2 in small cell lung cancer cell lines with oblimersen, an antisense BCL-2 oligodeoxynucleotide (ODN): in vitro and in vivo enhancement of radiation response.
Yohann Loriot, Pierre Mordant, Bob D Brown, Jean Bourhis, Jean-Charles Soria

Anticancer Res· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Palliative care training.
Catriona Curry, Heather Middleton, Bob Brown

Nurs Older People· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Attitudes and behavior of african-americans regarding the consumption of herbal products--an exploratory study.
Bob S Brown, Dennis Emmett, Ashish Chandra

J Hosp Mark Public Relations· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Downregulation of BCL-2 induces downregulation of carbonic anhydrase IX, vascular endothelial growth factor, and pAkt and induces radiation sensitization.
Satoshi Anai, Kathleen Shiverick, Theresa Medrano, Kogenta Nakamura, Steve Goodison, Bob D Brown

Urology· October 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis